Similar to the results with the cell lines, ex vivo coating of these primary tumor cells (Figure 4C) and primary CSCs (Figure 4D; Figure S4B in Supplementary Material) with anti-CD47 antibody, but not controls, resulted in complete inhibition of subcutaneous engraftment. Here, CD47 is linked to neoplasm.